Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1348) 1348
Publication (96) 96
Book / eBook (20) 20
Patent (16) 16
Conference Proceeding (13) 13
Book Review (12) 12
Book Chapter (9) 9
Dissertation (5) 5
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (632) 632
male (460) 460
female (420) 420
index medicus (413) 413
middle aged (252) 252
animals (220) 220
adult (198) 198
mice (182) 182
cardiac & cardiovascular systems (151) 151
aged (137) 137
prognosis (112) 112
pharmacology & pharmacy (97) 97
mice, knockout (93) 93
adolescent (90) 90
follow-up studies (87) 87
analysis (85) 85
risk factors (85) 85
clinical neurology (78) 78
child (74) 74
infectious diseases (73) 73
treatment outcome (69) 69
surgery (68) 68
p-glycoprotein (65) 65
young adult (65) 65
prospective studies (64) 64
research (64) 64
oncology (63) 63
mortality (62) 62
care and treatment (61) 61
children (61) 61
radiology, nuclear medicine & medical imaging (61) 61
immunology (58) 58
cardiology (57) 57
expression (57) 57
pharmacokinetics (57) 57
time factors (57) 57
diagnosis (55) 55
medicine & public health (53) 53
health aspects (51) 51
virology (51) 51
child, preschool (50) 50
coronary-artery-disease (50) 50
echocardiography (50) 50
retrospective studies (50) 50
genotype (47) 47
predictive value of tests (47) 47
biological transport (46) 46
tissue distribution (46) 46
sensitivity and specificity (45) 45
neurosciences (44) 44
reproducibility of results (43) 43
atp-binding cassette transporters - metabolism (41) 41
dobutamine (41) 41
hepatitis c virus (41) 41
prevalence (41) 41
biochemical research methods (40) 40
cardiovascular disease (40) 40
cohort studies (40) 40
risk (40) 40
cell line (39) 39
chemistry, analytical (39) 39
studies (39) 39
atp binding cassette transporter, sub-family g, member 2 (38) 38
cardiomyopathy (38) 38
disease (38) 38
liver - metabolism (38) 38
abridged index medicus (36) 36
heart attacks (36) 36
multidrug-resistance (36) 36
netherlands (36) 36
netherlands - epidemiology (36) 36
atp-binding cassette transporters - genetics (35) 35
cardiovascular (35) 35
hepacivirus - genetics (35) 35
liver (35) 35
risk assessment (35) 35
echocardiography, stress (34) 34
emission computed-tomography (34) 34
microbiology (34) 34
biochemistry & molecular biology (33) 33
brain - metabolism (33) 33
dogs (33) 33
mass spectrometry (33) 33
medicine, research & experimental (33) 33
biological availability (31) 31
heart failure (31) 31
medical research (31) 31
neuropsychological tests (31) 31
virus diseases (31) 31
atp-binding cassette, sub-family b, member 1 - metabolism (30) 30
cardiac patients (30) 30
epilepsy (30) 30
peripheral vascular disease (30) 30
physiological aspects (30) 30
cells (29) 29
gastroenterology & hepatology (29) 29
hiv (29) 29
infection (29) 29
public, environmental & occupational health (29) 29
blood-brain-barrier (28) 28
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Robarts - Stacks (15) 15
Collection Dvlpm't (Acquisitions) - Vendor file (3) 3
UTL at Downsview - May be requested (2) 2
UofT at Mississauga - Stacks (2) 2
Architecture Landscape (Shore + Moffat) - Stacks (1) 1
Art - Oversize (1) 1
Law (Bora Laskin) - Stacks (1) 1
Online Resources - Online (1) 1
St. Michael's College (John M. Kelly) - 2nd Floor (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text High treatment uptake in human immunodeficiency virus/ hepatitis C virus-coinfected patients after unrestricted access to direct-acting antivirals in the Netherlands
by Boerekamps, Anne and Newsum, Astrid M and Smit, Colette and Arends, Joop E and Richter, Clemens and Reiss, Peter and Rijnders, Bart J.A and Brinkman, Kees and Van Der Valk, Marc and Geerlings, S.E and Godfried, M.H and Goorhuis, A and Hovius, J.W and Van Der Meer, J.T.M and Kuijpers, T.W and Nellen, F.J.B and Van Der Poll, D.T and Prins, J.M and Van Vugt, H.J.M and Wiersinga, W.J and Wit, F.W.M.N and Van Duinen, M and Van Eden, J and Van Hes, A.M.H and Mutschelknauss, M and Nobel, H.E and Pijnappel, F.J.J and Weijsenfeld, A.M and Jurriaans, S and Back, N.K.T and Zaaijer, H.L and Berkhout, B and Cornelissen, M.T.E and Schinkel, C.J and Wolthers, K.C and Van Den Berge, M and Stegeman, A and Baas, S and Hage De Looff, L and Wintermans, B and Veenemans, J and Pronk, M.J.H and Ammerlaan, H.S.M and De Munnik, E.S and Jansz, A.R and Tjhie, J and Wegdam, M.C.A and Deiman, B and Scharnhorst, V and Van Eeden, A and Brokking, W and Groot, M and Elsenburg, L.J.M and Damen, M and Kwa, I.S and Van Kasteren, M.E.E and Brouwer, A.E and Van Erve, R and De Kruijf-Van De Wiel, B.A.F.M and Keelan-Pfaf, S and Van Der Ven, B and De Kruijf-Van De Wiel, B.A.F.M and Van Der Ven, B and Buiting, A.G.M and Kabel, P.J and Versteeg, D and Van Der Ende, M.E and Bax, H.I and Van Gorp, E.C.M and Nouwen, J.L and Schurink, C.A.M and Verbon, A and De Vries-Sluijs, T.E.M.S and De Jong-Peltenburg, N.C and Bassant, N and Van Beek, J.E.A and Vriesde, M and Van Zonneveld, L.M and Van Den Berg-Cameron, H.J and De Groot, J and De Zeeuw-De Man, M and Boucher, C.A.B and Koopmans, M.P.G and Van Kampen, J.J.A and Pas, S.D and Branger, J and Rijkeboer-Mes, A and Duijf-Van De Ven, C.J.H.M and Schippers, E.F and Van Nieuwkoop, C and Van IJperen, J.M and Geilings, J and Van Der Hut, G and Van Burgel, N.D and Leyten, E.M.S and Gelinck, L.B.S and Van Hartingsveld, A.Y and Meerkerk, C and Wildenbeest, G.S and Heikens, E and ... and Netherlands ATHENA HIV Observation and NVHB-SHM Hepatitis Working Grp and NVHB-SHM Hepatitis Working Group and the Netherlands ATHENA HIV Observational Cohort
Clinical Infectious Diseases, ISSN 1058-4838, 05/2018, Volume 66, Issue 9, pp. 1352 - 1359
Background. The Netherlands has provided unrestricted access to direct-acting antivirals (DAAs) since November 2015. We analyzed the nationwide hepatitis C... 
Treatment uptake | HIV/HCV coinfection | Direct-acting antivirals | treatment uptake | INFECTIOUS DISEASES | EFFICACY | SAFETY | SEX | MICROBIOLOGY | IMMUNOLOGY | direct-acting antivirals | INDIVIDUALS | HIV | REINFECTION | MEN | INFECTION | COHORT | AMSTERDAM
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text MSM starting preexposure prophylaxis are at risk of hepatitis C virus infection
by Hoornenborg, Elske and Achterbergh, Roel C. A and Schim van der Loeff, Maarten F and Davidovich, Udi and Hogewoning, Arjan and de Vries, Henry J. C and Schinkel, Janke and Prins, Maria and van de Laar, Thijs J. W and HIV Transmission Elimination AMste and MOSAIC Study Grp and Amsterdam PrEP Project team in the HIV Transmission Elimination AMsterdam Initiative, MOSAIC study group
AIDS (London, England), ISSN 0269-9370, 2017, Volume 31, Issue 11, pp. 1603 - 1610
Objectives and design:Hepatitis C virus (HCV) has been recognized as an emerging sexually transmitted infection (STI) among HIV-positive MSM. However,... 
molecular epidemiology | hepatitis C virus | prevention of sexual transmission | risk factors | preexposure prophylaxis | MSM | CLEARANCE | INFECTIOUS DISEASES | GENOTYPE | SEX | HIV-NEGATIVE MEN | IMMUNOLOGY | TRANSMISSION | VIROLOGY | Hepacivirus - drug effects | Prevalence | Prospective Studies | Pre-Exposure Prophylaxis - utilization | Humans | Netherlands - epidemiology | Risk Factors | Genotype | Male | Patient Acceptance of Health Care - statistics & numerical data | Phylogeny | HIV Seronegativity - immunology | Hepatitis C - immunology | Unsafe Sex - statistics & numerical data | Homosexuality, Male | Adult | Hepatitis C Antibodies - genetics | Hepatitis C - prevention & control | HIV Seropositivity - immunology | Longitudinal Studies | Hepatitis C - transmission | HIV Seropositivity - virology
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Progression of liver fibrosis following acute hepatitis C virus infection in HIV-positive MSM
by Newsum, Astrid M and Kooij, Katherine W and Boyd, Anders and Smit, Colette and Wit, Ferdinand W.N.M and van der Meer, Jan T.M and Prins, Maria and Reiss, Peter and van der Valk, Marc and ATHENA Observational HIV Cohort and MOSAIC Study Grp and MOSAIC study group, ATHENA observational HIV cohort and NVHB-SHM hepatitis working group
AIDS, ISSN 0269-9370, 04/2019, Volume 33, Issue 5, pp. 833 - 844
BACKGROUND:Whether continued, accelerated liver fibrosis progression occurs following acute hepatitis C virus infection (AHCVI) in HIV-positive MSM is unknown.... 
INFECTIOUS DISEASES | HIV/hepatitis C virus coinfection | MSM | STAGE | NONINVASIVE INDEX | SEX | RISK | ANTIRETROVIRAL THERAPY | IMMUNOLOGY | INDIVIDUALS | liver fibrosis | HEPATOCELLULAR-CARCINOMA | VIROLOGY | fibrosis-4 | MEN | DISEASE | IMMUNODEFICIENCY | acute hepatitis C virus infection | Complications and side effects | Development and progression | Hepatitis C | Liver cirrhosis | MSM (Men who have sex with men) | Health aspects | Risk factors
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Development and validation of a risk score for chronic kidney disease in HIV infection using prospective cohort data from the D:A:D study
by Mocroft, Amanda and Lundgren, Jens D and Ross, Michael and Law, Matthew and Reiss, Peter and Kirk, Ole and Smith, Colette and Wentworth, Deborah and Neuhaus, Jacqueline and Fux, Christoph A and Moranne, Olivier and Morlat, Phillipe and Johnson, Margaret A and Ryom, Lene and Lundgren, J. D and Powderly, B and Shortman, N and Moecklinghoff, C and Reilly, G and Franquet, X and Sabin, C. A and Phillips, A and Kirk, O and Weber, R and Pradier, C and Law, M and d'Arminio Monforte, A and Dabis, F and El-Sa, W. M and de Wit, S and Ryom, L and Kamara, D and Smith, C and Mocroft, A and Tverland, J and Mansfeld, M and Nielsen, J and Raben, D and Salbøl Brandt, R and Rickenbach, M and Fanti, I and Krum, E and Hillebregt, M and Geffard, S and Sundström, A and Delforge, M and Fontas, E and Torres, F and McManus, H and Wright, S and Kjær, J and Sjøl, A and Meidahl, P and Helweg-Larsen, J and Schmidt Iversen, J and Ross, M and Fux, C. A and Morlat, P and Moranne, O and Kesselring, A. M and Kamara, D. A and Friis-Møller, N and Kowalska, J and Sabin, C and Bruyand, M and Bower, M and Fätkenheuer, G and Donald, A and Grulich, A and Prins, J. M and Kuijpers, T. W and Scherpbier, H. J and van der Meer, J. T. M and Wit, F. W. M. N and Godfried, M. H and van der Poll, T and Nellen, F. J. B and Geerlings, S. E and van Vugt, M and Pajkrt, D and Bos, J. C and Wiersinga, W. J and van der Valk, M and Goorhuis, A and Hovius, J. W and van Eden, J and Henderiks, A and van Hes, A. M. H and Mutschelknauss, M and Nobel, H. E and Pijnappel, F. J. J and Westerman, A. M and Jurriaans, S and Back, N. K. T and Zaaijer, H. L and Berkhout, B and Cornelissen, M. T. E and Schinkel, C. J and Thomas, X. V and de Ruyter Ziekenhuis, Admiraal and ... and Royal Free Hosp Clin Cohort and INSIGHT Study Grp and DAD Study Grp and SMART Study Grp and ESPRIT Study Grp and D:A:D study group and Royal Free Hospital Clinic Cohort and SMART study group and INSIGHT study group and ESPRIT study group and D:A:D study group, the Royal Free Hospital Clinic Cohort, and the INSIGHT, SMART, and ESPRIT study groups
PLoS medicine, ISSN 1549-1277, 2015, Volume 12, Issue 3, pp. e1001809 - e1001809
Chronic kidney disease (CKD) is a major health issue for HIV-positive individuals, associated with increased morbidity and mortality. Development and... 
INDIVIDUALS | GLOMERULAR-FILTRATION-RATE | MEDICINE, GENERAL & INTERNAL | POSITIVE PERSONS | PROTEINURIA | ANTIRETROVIRAL THERAPY | ASSOCIATION | STAGE RENAL-DISEASE | LIFE EXPECTANCY | EXPOSURE | PREDICTION | Kidney - drug effects | Prospective Studies | Age Factors | Kidney - pathology | Renal Insufficiency, Chronic - etiology | Risk Assessment | Comorbidity | HIV Seropositivity - complications | Anti-HIV Agents - adverse effects | Humans | Middle Aged | Male | Risk | CD4 Lymphocyte Count | Incidence | Renal Insufficiency, Chronic - epidemiology | HIV | Clinical Decision-Making | HIV Infections - complications | Sex Factors | Adult | Anti-HIV Agents - therapeutic use | Female | HIV Infections - drug therapy | Index Medicus | Life Sciences | Human health and pathology | Santé publique et épidémiologie | Infectious diseases | Urology and Nephrology | Hypertension | Antiretroviral drugs | Mortality | Cardiovascular disease | Infections | Studies | Hepatitis | Data collection | Human immunodeficiency virus | Diabetes | Kidney diseases | Drug use
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Sofosbuvir plus simeprevir for the treatment of HCV genotype 4 patients with advanced fibrosis or compensated cirrhosis is highly efficacious in real life
by Willemse, S. B and Baak, L. C and Kuiken, S. D and van der Sluys Veer, A and Lettinga, K. D and van der Meer, J. T. M and Depla, A. C. T. M and Tuynman, H and van Nieuwkerk, C. M. J and Schinkel, C. J and Kwa, D and Reesink, H. W and van der Valk, M
Journal of viral hepatitis, ISSN 1352-0504, 2016, Volume 23, Issue 12, pp. 950 - 954
Chronic hepatitis C virus (HCV) infection is a major cause of chronic liver disease and liver-related death. Recently, multiple regimens of different... 
sofosbuvir | HCV genotype 4 | simeprevir | direct‐acting antivirals (DAAs) | direct-acting antivirals (DAAs) | CHRONIC HEPATITIS | INFECTIOUS DISEASES | RIBAVIRIN | PHASE-3 | VIROLOGY | C VIRUS-INFECTION | PEGYLATED INTERFERON | DOUBLE-BLIND | INTERFERON-ALPHA 2A | GASTROENTEROLOGY & HEPATOLOGY | TREATMENT-NAIVE PATIENTS | Sofosbuvir - therapeutic use | Hepacivirus - isolation & purification | Recurrence | Antiviral Agents - therapeutic use | Humans | Middle Aged | Protease Inhibitors | Hepacivirus - genetics | Hepatitis C, Chronic - virology | Genotype | Male | Treatment Outcome | Hepatitis C, Chronic - complications | Hepatitis C, Chronic - drug therapy | Simeprevir - therapeutic use | Netherlands | Liver Cirrhosis - virology | Liver Cirrhosis - pathology | Adult | Female | Aged | Hepacivirus - classification | Retrospective Studies | Antiviral agents | Care and treatment | Fibrosis | Genetic aspects | Hepatitis C | Biological response modifiers | Hepatitis C virus | Liver cirrhosis
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Prevalence and Clinical Outcomes of Poor Immune Response Despite Virologically Suppressive Antiretroviral Therapy Among Children and Adolescents With Human Immunodeficiency Virus in Europe and Thailand: Cohort Study
by Chappell, Elizabeth and Riordan, Andrew and Jourdain, Gonzague and Soriano-Arandes, Antoni and Ene, Luminita and Scherpbier, Henriette J and Warszawski, Josiane and Collins, Intira J and Smit, Colette and Marques, Laura and Klein, Nigel and Guillén, Sara and Judd, Ali and Thorne, Claire and Goodall, Ruth and Königs, Christoph and Spoulou, Vana and Prata, Filipa and Goetghebuer, Tessa and Chiappini, Elena and Galli, Luisa and Naver, Lars and Giaquinto, Carlo and M Gibb, Diana and Gibb, Diana M and Marczynska, Magdalena and Okhonskaia, Liubov and Klimkait, Thomas and Lallemant, Marc and Ngo-Giang-Huong, Nicole and Kiseleva, Galyna and Malyuta, Ruslan and Volokha, Alla and Hainaut, Marc and Delforge, Marc and Le Chenadec, Jerome and Ramos, Elisa and Dialla, Olivia and Wack, Thierry and Laurent, Corine and Ait si Selmi, Lamya and Leymarie, Isabelle and Ait Benali, Fazia and Brossard, Maud and Boufassa, Leila and Floch-Tudal, Corinne and Firtion, Ghislaine and Hau, Isabelle and Chace, Anne and Bolot, Pascal and Blanche, Stéphane and Levine, Martine and Bicëtre, Le Kremlin and Fourcade, Corinne and Heller-Roussin, Brigitte and Runel-Belliard, Camille and Tricoire, Joëlle and Chirouze, Catherine and Reliquet, Véronique and Brouard, Jacques and Kebaili, Kamila and Fialaire, Pascale and Lalande, Muriel and Schultze-Strasser, Stephan and Baumann, U and Niehues, T and Neubert, J and Kobbe, R and Berlin, Charite and Feiterna-Sperling, C and Königs, C and Buchholz, B and Notheis, G and de Martino, Maurizio and Angelo Tovo, Pier and Patrizia, Osimani and Larovere, Domenico and Ruggeri, Maurizio and Faldella, Giacomo and Baldi, Francesco and Badolato, Raffaele and Montagnani, Carlotta and Venturini, Elisabetta and Lisi, Catiuscia and Di Biagio, Antonio and Taramasso, Lucia and Giacomet, Vania and Erba, Paola and Esposito, Susanna and Lipreri, Rita and Salvini, Filippo and Tagliabue, Claudia and Cellini, Monica and Bruzzese, Eugenia and Lo Vecchio, Andrea and Rampon, Osvalda and Donà, Daniele and Romano, Amelia and Dodi, Icilio and Maccabruni, Anna and ... and The European Pregnancy and Paediatric HIV Cohort Collaboration (EPPICC) Study Group in EuroCoord
Clinical Infectious Diseases, ISSN 1058-4838, 03/2019
Abstract Background In human immunodeficiency virus (HIV)–positive adults, low CD4 cell counts despite fully suppressed HIV-1 RNA on antiretroviral therapy... 
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights